HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Expert Panel’s 151st Meeting Marked By High Preservatives Content

Executive Summary

Parabens, polyaminopropyl biguanide, imidazolidinyl urea and combination methylisothiazolinone/methylchloroisothiazolinone (MI/MCI) all came under scrutiny at the CIR Expert Panel’s June 6-7 meeting. HBW Insight discusses the mixed results and provides a full table of panel findings.

You may also be interested in...



NGO Women’s Voices Will Keep After CIR Following 2019 Progress – Science Director Alex Scranton

Alexandra Scranton, director of science and research at Women’s Voices for the Earth, highlights achievements in 2019 in the group’s Cosmetic Ingredient Review-focused activities, including parameters the Expert Panel placed on preservative use of parabens, PHMB and MCI/MI.

CIR Expert Panel Proposes Parabens Use Restriction, Still Confident In Safety Overall

The Cosmetic Ingredient Review’s independent experts issued a tentative amended report for 21 parabens at their June meeting in Washington, triggering a new public comment period. The panel continues to back the safety of parabens, including a number that are banned or heavily restricted in Europe, but now recommends limiting parabens’ total concentration in finished cosmetics to 0.8%.

CIR Expert Panel’s April Meeting: 82 Brown Algae Ingredients Reviewed; Preservative Developments; More

The Cosmetic Ingredient Review Expert Panel is taking its first look at brown algae-derived ingredients, with 32 passing muster at the panel’s April 8-9 meeting in Washington. Salicylic acid and fatty acids were among ingredients that received final safe verdicts, while four ingredient groups drew insufficient data announcements. Finally, parabens got tabled and MCI/MI was reopened for updates.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel